Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2015 | $521,964 | | tax credit/rebate |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2011 | $519,533 | | tax credit/rebate; property tax abatement |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2007 | $518,618 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2018 | $518,535 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2015 | $516,584 | | tax credit/rebate |
Doral/Pfizer | Pfizer | New York | local | 2013 | $516,004 | | tax credit/rebate; property tax abatement |
LightLab Imaging, Inc | Abbott Laboratories | Massachusetts | state | 2012 | $515,000 | | tax credit/rebate |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2013 | $514,750 | | property tax abatement |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hospira, Inc. | Pfizer | North Carolina | state | 2021 | $512,192 | | tax credit/rebate |
C3i, Inc. | Merck | Pennsylvania | state | | $512,000 | | tax credit/rebate |
C3i, Inc. | Merck | Pennsylvania | state | 2014 | $512,000 | | tax credit/rebate |
Aventis Pasteur USA | Sanofi | Pennsylvania | state | | $509,900 | | training reimbursement |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2017 | $506,455 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2014 | $506,133 | | tax credit/rebate |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2017 | $502,233 | | training reimbursement |
Pfizer, Inc. | Pfizer | North Carolina | state | 2011 | $501,793 | | tax credit/rebate |
Genentech USA, Inc | Roche | Oregon | state | 2019 | $500,260 | | grant |
Novartis Animal Health US, Inc. | Novartis | Iowa | state | 2007 | $500,000 | | grant/loan hybrid program |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2007 | $500,000 | | grant |
Wyeth-Ayerst Pharmaceuticals | Pfizer | Pennsylvania | state | | $500,000 | | grant |
Aventis Pasteur USA | Sanofi | Pennsylvania | state | | $500,000 | | grant |
Wyeth Pharmaceuticals, Inc. | Pfizer | Pennsylvania | state | | $500,000 | | grant |
Lannett Company, Inc. | Lannett Co. | Pennsylvania | state | | $500,000 | | grant |
Johnson & Johnson Sales and Logistics Company, LLC | Johnson & Johnson | Pennsylvania | state | | $500,000 | | grant |
Barr Laboratories Inc. | Teva Pharmaceutical Industries | Virginia | state | 2008 | $500,000 | | grant |
MedImmune, Inc. | AstraZeneca | Maryland | local | | $500,000 | | grant/loan hybrid program |
Eli Lilly dba Elanco Animal Health | Eli Lilly | Indiana | state | 2013 | $500,000 | | grant |
Wyeth-Lederle (#2) | Pfizer | North Carolina | state | 2004 | $500,000 | | grant |
Novitas Solutions, Inc. | Novartis | Florida | state | 2013 | $500,000 | | tax credit/rebate |
Anda Pharmaceuticals, Inc. | AbbVie | Mississippi | state | 2012 | $500,000 | | grant |
C3i, Inc. | Merck | Pennsylvania | state | | $500,000 | | grant |
Pfizer, Inc. | Pfizer | New York | state | 2005 | $500,000 | | enterprise zone |
United Therapeutics | United Therapeutics | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
Intervet, Inc. D/B/A Merck | Merck | Nebraska | state | 2019 | $500,000 | | grant |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2019 | $500,000 | | grant/loan hybrid program |
Merck | Merck | Virginia | state | 2007 | $500,000 | | grant |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2020 | $497,199 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2018 | $495,412 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2005 | $495,039 | | tax credit/rebate; property tax abatement |
Emergent Biosolutions | Emergent BioSolutions | Maryland | local | 2013 | $495,000 | | grant |
Acorda Therapeutics, Inc. | Acorda Therapeutics | Massachusetts | state | 2017 | $495,000 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | Local | 2018 | $494,593 | | tax credit/rebate |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $494,275 | | grant/loan hybrid program |
Medimmune, LLC | AstraZeneca | Maryland | state | 2009 | $490,223 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2013 | $490,000 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2011 | $488,081 | | tax credit/rebate; property tax abatement |
IMMUNEX CORPORATION | Amgen | Washington | state | 2006 | $485,991 | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2008 | $485,631 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $483,750 | | grant |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2004 | $481,822 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2011 | $481,489 | | tax credit/rebate |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2007 | $478,724 | | tax credit/rebate; property tax abatement |
Novozymes Blair, Inc. | Novo Holdings A/S | Nebraska | state | 2023 | $475,775 | | tax rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2008 | $474,786 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New Jersey | state | 2008 | $471,219 | | grant |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2013 | $470,487 | | tax credit/rebate; property tax abatement |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2017 | $467,431 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | Iowa | state | 2007 | $466,425 | | tax credit/rebate |
Auxilium Pharmacueticals, Inc. | Endo International | Pennsylvania | state | 2013 | $465,755 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2012 | $464,160 | | tax credit/rebate; property tax abatement |
Doral/Pfizer | Pfizer | New York | local | 2008 | $462,392 | | tax credit/rebate; property tax abatement |
Medimmune, LLC | AstraZeneca | Maryland | state | 2011 | $462,285 | | tax credit/rebate |
Endo Pharmaceuticals | Endo International | Pennsylvania | state | | $462,000 | | tax credit/rebate |
Abiomed, Inc | Johnson & Johnson | Massachusetts | state | 2019 | $459,125 | | tax credit/rebate |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $458,408 | | training reimbursement |
C3i Incorporated | Merck | Pennsylvania | state | | $458,000 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2017 | $456,553 | | tax credit/rebate |
Ventana Medical Systems, Inc. | Roche | Arizona | state | 2007 | $454,796 | | training reimbursement |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2012 | $454,512 | | tax credit/rebate |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Viropharma Incorporated | Takeda Pharmaceutical | Pennsylvania | state | | $453,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $452,785 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. & Affiliates | Novartis | Nebraska | state | 2007 | $452,433 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2014 | $452,064 | | tax credit/rebate |
Mylan Inc. | Viatris | Pennsylvania | state | | $450,000 | | tax credit/rebate |
Moderna Therapeutics | Moderna Inc. | Massachusetts | state | 2014 | $450,000 | | tax credit/rebate |
Sucampo Pharmaceuticals, Inc. | Mallinckrodt | Maryland | state | 2016 | $450,000 | | grant/loan hybrid program |
Merck (2015) | Merck | Virginia | state | 2016 | $450,000 | | training reimbursement |
Merck (2015) | Merck | Virginia | state | 2017 | $450,000 | | training reimbursement |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2016 | $446,809 | | tax credit/rebate |
United Therapeutics Corp | United Therapeutics | North Carolina | state | 2011 | $444,809 | | tax credit/rebate |
Ventana Medical Systems, Inc. | Roche | Arizona | state | 2005 | $443,248 | | training reimbursement |
Mallinckrodt Enterprises | Mallinckrodt | North Carolina | state | 2012 | $441,576 | | tax credit/rebate |
HOSPIRA, INC. | Pfizer | California | state | 2006 | $439,595 | | training reimbursement |
Immunex Corporation | Amgen | Pennsylvania | state | 2011 | $437,312 | | tax credit/rebate |
SmithKline Beecham Corporation DBA GlaxoSmithKline | GlaxoSmithKline | Pennsylvania | state | 2010 | $435,635 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2015 | $435,182 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2014 | $432,501 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2009 | $429,500 | | tax credit/rebate |
Pfizer Inc., and Subsidiaries | Pfizer | Maryland | state | 2015 | $427,891 | | tax credit/rebate |
Auxilium Pharmacueticals, Inc. | Endo International | Pennsylvania | state | 2014 | $426,723 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2013 | $426,654 | | tax credit/rebate; property tax abatement |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2007 | $425,295 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2019 | $420,445 | | tax credit/rebate |